Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 6 (June)

1. Late obstruction of an endoscopic third ventriculostomy stoma by metastatic seeding of a recurrent medulloblastoma.
   J Neurosurg Pediatr, 5(6): 641-4. [Abstract] [Full-text]
2. Pineal anlage tumor in a 5-month-old boy.
   J Neurosurg Pediatr, 5(6): 636-40. [Abstract] [Full-text]
3. Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.
   J Neurosurg Pediatr, 5(6): 615-21. [Abstract] [Full-text]
4. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
   J Neurosurg Pediatr, 5(6): 608-14. [Abstract] [Full-text]
5. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
   Cancer Res, 70(11): 4274-9. [Abstract] [Full-text]
6. Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.
   Cancer Res, 70(11): 4520-7. [Abstract] [Full-text]
7. Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.
   Cancer Res, 70(11): 4499-508. [Abstract] [Full-text]
8. A partially ossified solid and cystic Rathke cleft cyst.
   J Neurosurg, 112(6): 1324-6. [Abstract] [Full-text]
9. Fluid-fluid level in pituitary tumors: analysis of management of 106 cases.
   J Neurosurg, 112(6): 1341-6. [Abstract] [Full-text]
10. Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?
    Cancer Invest, 28(6): 608-14. [Abstract] [Full-text]
11. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.
    Nat Med, 16(6): 671-7. [Abstract] [Full-text]
12. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    J Clin Endocrinol Metab, 95(6): 2672-9. [Abstract] [Full-text]
13. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
    Am J Clin Oncol, 33(3): 265-70. [Abstract] [Full-text]
14. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.
    Neurology, 74(23): 1886-90. [Abstract] [Full-text]
15. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures.
    Oncogene, 29(23): 3411-22. [Abstract] [Full-text]
16. Biomaterial-based technologies for brain anti-cancer therapeutics and imaging.
    Biochim Biophys Acta, 1806(1): 96-107. [Abstract] [Full-text]
17. Metastasectomy for stage IV colorectal cancer.
    Dis Colon Rectum, 53(7): 1080-92. [Abstract] [Full-text]
18. The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro.
    Cancer Chemother Pharmacol, 66(3): 611-6. [Abstract] [Full-text]
19. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma.
    Oncogene, 29(24): 3465-76. [Abstract] [Full-text]
20. CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity.
    Am J Physiol Cell Physiol, 299(1): C175-84. [Abstract] [Full-text]
21. 18F-FET-PET-based dose painting by numbers with protons.
    Strahlenther Onkol, 186(6): 320-6. [Abstract] [Full-text]
22. Comparison of the effectiveness of "late" and "early" prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
    Strahlenther Onkol, 186(6): 315-9. [Abstract] [Full-text]
23. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
    J Clin Oncol, 28(18): 3054-60. [Abstract] [Full-text]
24. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.
    J Clin Oncol, 28(18): 3069-75. [Abstract] [Full-text]
25. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.
    J Clin Oncol, 28(18): 3061-8. [Abstract] [Full-text]
26. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
    J Clin Oncol, 28(18): 3048-53. [Abstract] [Full-text]
27. Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.
    BMC Cancer, 10: 257. [Abstract] [Full-text]
28. Vision-related quality of life after transsphenoidal surgery for pituitary adenoma.
    Invest Ophthalmol Vis Sci, 51(7): 3405-10. [Abstract] [Full-text]
29. Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review.
    Cancer, 116(13): 3084-92. [Abstract] [Full-text]
30. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein.
    Apoptosis, 15(7): 753-68. [Abstract] [Full-text]
31. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.
    Brain, 133: 1961-72. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.